Editorial: Food for Thought—Addressing the Nuances of Diet and Mood When Evaluating Dietary Intervention in IBS. Authors' Reply

IF 6.7 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Alimentary Pharmacology & Therapeutics Pub Date : 2024-11-07 DOI:10.1111/apt.18384
Anthony O'Connor, Sarah Gill, Elaine Neary, Sarah White, Alexander C. Ford
{"title":"Editorial: Food for Thought—Addressing the Nuances of Diet and Mood When Evaluating Dietary Intervention in IBS. Authors' Reply","authors":"Anthony O'Connor,&nbsp;Sarah Gill,&nbsp;Elaine Neary,&nbsp;Sarah White,&nbsp;Alexander C. Ford","doi":"10.1111/apt.18384","DOIUrl":null,"url":null,"abstract":"<p>We thank Drs Katzenstein and Keefer for their editorial on our paper [<span>1, 2</span>]. We fully agree on the need for progress towards an integrated, personalised model of care for patients with disorders of gut-brain interaction. We are aware of the limitations of the Hospital Anxiety and Depression Scale (HADS) and concur that it does not capture all the psychological nuances seen in patients with irritable bowel syndrome (IBS). However, it is easily understood and administered by non-specialist practitioners and has been used across a range of DGBIs by others [<span>3</span>]. Although the imperative for the development of symptom-specific questionnaires, specific psychosocial questionnaires and inclusion of psychosocial well-being have been championed by expert opinion, none was in use at the time of our study, and none has since emerged [<span>4</span>].</p><p>As the study was conducted in routine clinical practice and at the time of the Coronavirus pandemic, many patients were consulted with remotely. We believed it would have been difficult to repeat the HADS post-intervention. In addition, around the time of lockdown restrictions related to the pandemic, observed incidences of anxiety and depression were increased [<span>5</span>]. In such a setting, to infer that any changes observed in HADS over the period of the intervention were due to dietary therapy or IBS symptom status alone may have been an over-simplification.</p><p>The vast majority of patients with IBS are, and will continue to be, treated in primary and secondary care by either generalist physicians and dietitians or others with a subspeciality interest in the field. We, therefore, contend that the design and findings of our study are broadly generalisable to existing models of care and show promising results even in patients with more severe symptoms, overlapping symptomatology and poor psychological health, which will resonate with clinical practitioners across disciplines. Like Drs Katzenstein and Keefer, we look forward to the type of studies that will lead to greater comprehension of the intersection of food and mood, and to uncover the underlying mechanisms at play. Until then, evidence from studies such as our own—that may improve understanding of how psychological parameters could predict response to commonly used interventions—is an important step towards personalising care for patients with IBS.</p><p><b>Anthony O'Connor:</b> conceptualization, investigation, writing – original draft, methodology, writing – review and editing, visualization, validation, formal analysis, data curation, project administration. <b>Sarah Gill:</b> conceptualization, investigation, methodology, validation, formal analysis, data curation. <b>Elaine Neary:</b> conceptualization, investigation, methodology, validation, data curation. <b>Sarah White:</b> conceptualization, investigation, methodology, formal analysis. <b>Alexander C. Ford:</b> writing – original draft, writing – review and editing, formal analysis, supervision.</p><p>This article is linked to O’Connor et al papers. To view these articles, visit https://doi.org/10.1111/apt.18337 and https://doi.org/10.1111/apt.18372.</p>","PeriodicalId":121,"journal":{"name":"Alimentary Pharmacology & Therapeutics","volume":"61 1","pages":"200-201"},"PeriodicalIF":6.7000,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apt.18384","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alimentary Pharmacology & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/apt.18384","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

We thank Drs Katzenstein and Keefer for their editorial on our paper [1, 2]. We fully agree on the need for progress towards an integrated, personalised model of care for patients with disorders of gut-brain interaction. We are aware of the limitations of the Hospital Anxiety and Depression Scale (HADS) and concur that it does not capture all the psychological nuances seen in patients with irritable bowel syndrome (IBS). However, it is easily understood and administered by non-specialist practitioners and has been used across a range of DGBIs by others [3]. Although the imperative for the development of symptom-specific questionnaires, specific psychosocial questionnaires and inclusion of psychosocial well-being have been championed by expert opinion, none was in use at the time of our study, and none has since emerged [4].

As the study was conducted in routine clinical practice and at the time of the Coronavirus pandemic, many patients were consulted with remotely. We believed it would have been difficult to repeat the HADS post-intervention. In addition, around the time of lockdown restrictions related to the pandemic, observed incidences of anxiety and depression were increased [5]. In such a setting, to infer that any changes observed in HADS over the period of the intervention were due to dietary therapy or IBS symptom status alone may have been an over-simplification.

The vast majority of patients with IBS are, and will continue to be, treated in primary and secondary care by either generalist physicians and dietitians or others with a subspeciality interest in the field. We, therefore, contend that the design and findings of our study are broadly generalisable to existing models of care and show promising results even in patients with more severe symptoms, overlapping symptomatology and poor psychological health, which will resonate with clinical practitioners across disciplines. Like Drs Katzenstein and Keefer, we look forward to the type of studies that will lead to greater comprehension of the intersection of food and mood, and to uncover the underlying mechanisms at play. Until then, evidence from studies such as our own—that may improve understanding of how psychological parameters could predict response to commonly used interventions—is an important step towards personalising care for patients with IBS.

Anthony O'Connor: conceptualization, investigation, writing – original draft, methodology, writing – review and editing, visualization, validation, formal analysis, data curation, project administration. Sarah Gill: conceptualization, investigation, methodology, validation, formal analysis, data curation. Elaine Neary: conceptualization, investigation, methodology, validation, data curation. Sarah White: conceptualization, investigation, methodology, formal analysis. Alexander C. Ford: writing – original draft, writing – review and editing, formal analysis, supervision.

This article is linked to O’Connor et al papers. To view these articles, visit https://doi.org/10.1111/apt.18337 and https://doi.org/10.1111/apt.18372.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
社论:思考的食物--在评估肠易激综合征的饮食干预时解决饮食与情绪的细微差别。作者回复。
我们感谢Katzenstein和Keefer博士对我们论文的评论[1,2]。我们完全同意有必要为肠-脑相互作用障碍患者建立一个综合的、个性化的护理模式。我们意识到医院焦虑和抑郁量表(HADS)的局限性,并同意它不能捕捉到肠易激综合征(IBS)患者所有心理上的细微差别。然而,它很容易被非专业从业人员理解和管理,并已被其他人用于一系列dgbi[10]。虽然专家意见支持开发症状特异性问卷、特定心理社会问卷和纳入心理社会健康的必要性,但在我们研究时没有使用过,而且自那以后也没有出现过。由于该研究是在常规临床实践中进行的,而且正值冠状病毒大流行时期,许多患者接受了远程咨询。我们认为干预后很难重复HADS。此外,在与大流行有关的封锁限制期间,观察到的焦虑和抑郁发生率增加了100万。在这种情况下,推断干预期间HADS观察到的任何变化是由于饮食治疗或IBS症状状态本身可能过于简单化。绝大多数肠易激综合征患者现在并将继续由全科医生和营养师或其他对该领域感兴趣的亚专科医生在初级和二级护理中进行治疗。因此,我们认为,我们研究的设计和发现可以广泛地推广到现有的护理模式,并且即使在症状更严重、症状重叠和心理健康状况较差的患者中也显示出有希望的结果,这将与跨学科的临床从业者产生共鸣。像卡岑斯坦博士和基弗博士一样,我们期待着能够更好地理解食物和情绪之间的交集,并揭示其中的潜在机制的研究类型。在此之前,来自我们自己的研究的证据——可能会提高对心理参数如何预测对常用干预措施的反应的理解——是对肠易激综合征患者个性化护理的重要一步。Anthony O'Connor:概念化、调查、写作——原稿、方法论、写作——审查和编辑、可视化、验证、形式分析、数据管理、项目管理。Sarah Gill:概念化、调查、方法论、验证、形式分析、数据管理。Elaine Neary:概念化、调查、方法论、验证、数据管理。莎拉·怀特:概念化、调查、方法论、形式分析。亚历山大·福特:写作-原稿,写作-审查和编辑,形式分析,监督。这篇文章链接到O’connor等人的论文。要查看这些文章,请访问https://doi.org/10.1111/apt.18337和https://doi.org/10.1111/apt.18372。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
15.60
自引率
7.90%
发文量
527
审稿时长
3-6 weeks
期刊介绍: Alimentary Pharmacology & Therapeutics is a global pharmacology journal focused on the impact of drugs on the human gastrointestinal and hepato-biliary systems. It covers a diverse range of topics, often with immediate clinical relevance to its readership.
期刊最新文献
Post-Operative Recurrence of Colonic Crohn's Disease After Colectomy: The RESECOL Study by the Young Group of GETECCU. Real-World Alcohol Use Disorder Outcomes in Patients With Concurrent Metabolic Dysfunction: GLP-1 Receptor Agonists Versus FDA-Approved AUD Medications. Letter: Eating Disorders in Inflammatory Bowel Disease-Are We Asking the Right Questions? Letter: Improving the Interpretability and Portability of Tumour Burden Score-Based Prediction of Extrahepatic Progression After Transarterial Chemoembolization (TACE). Letter: Improving the Interpretability and Portability of Tumour Burden Score-Based Prediction of Extrahepatic Progression After Transarterial Chemoembolisation (TACE)-Author's Reply.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1